Profil
Christophe Bancel is the founder of iBionext SAS, founded in 2012, serving as Venture Partner since 2012.
Mr. Bancel is the founder of Tissium SA, founded in 2013, serving as Chief Executive Officer & Director since 2013.
Former job includes Director at BrainEver SAS.
Postes actifs de Christophe Bancel
| Sociétés | Poste | Début |
|---|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Fondateur | 01/01/2013 |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Fondateur | 01/10/2012 |
Anciens postes connus de Christophe Bancel
| Sociétés | Poste | Fin |
|---|---|---|
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Finance |
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Health Technology |
















